Uptick Network

The Stock Day Podcast welcomed Lexaria Bioscience Corp. (LXRP)(“the Company”), known for its proprietary drug delivery technology, DehydraTECH™, which improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. CEO of the Company, Chris Bunka, joined Stock Day host Everett Jolly. READ FULL PRESS RELEASE HERE: https://stockdaymedia.com/lexaria-bioscience-corp-discusses-the-significance-of-their-intellectual-property-with-the-stock-day-podcast-lxrp-november-17-2020/